Glenmark Pharmaceuticals receives USFDA approval for Tadalafil Tablets

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (USFDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, the generic version of Cialis1 Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg, of Eli Lilly and Company.

According to IQVIATM sales data for the 12 month period ending November 2020, the Cialis Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg market2 achieved annual sales of approximately $125.5 million.

Powered by Capital Market - Live News